{"symbol": "FWP", "companyName": "Forward Pharma A/S", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.forward-pharma.com", "description": "Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.", "CEO": "Claus Bo Svendsen", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}